Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Natco Pharma LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:524816NSE Symbol: NATCOPHARMP/E(TTM):9.79
ISIN Demat:INE987B01026Div & Yield %:0.72EPS(TTM):84.75
Book Value(Rs):461.79599Market Cap ( Cr.):14867.91Face Value(Rs):2
    Change Company 
Date Headline
14-Nov-25 Board of Natco Pharma recommends interim dividend
14-Nov-25 Natco Pharma fixes record date for interim dividend
14-Nov-25 Natco Pharma consolidated net profit declines 23.46% in the September 2025 quarter
10-Nov-25 Natco Pharma to conduct board meeting
07-Nov-25 Natco Pharma Ltd - Natco Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates
31-Oct-25 Natco Pharma launches Everolimus tablets 1mg
31-Oct-25 Natco Pharma Ltd - Natco Pharma Limited - Press Release
17-Oct-25 Natco Pharma Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release
17-Oct-25 Natco Pharma Ltd - Natco Pharma Limited - Press Release
10-Oct-25 Volumes spurt at Tata Communications Ltd counter
<< < 1 2 3 4   > >>